The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 clinical update of IMA203, an autologous TCR-T targeting PRAME in patients with PD1 refractory metastatic melanoma.
 
Martin Wermke
Honoraria - Amgen; BMS GmbH & Co. KG; Boehringer Ingelheim; GWT; Janssen; Lilly; Merck Serono; Merck Serono; Novartis; Pfizer; SYNLAB
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; ImCheck therapeutics; immatics; ISA Pharmaceuticals; Lilly; Novartis; PharmaMar; Regeneron; Tacalyx; Zymeworks
Research Funding - Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; Bristol-Myers Squibb; Daiichi Sankyo Europe GmbH; GEMoaB; immatics; Iovance Biotherapeutics; Janssen Oncology; Merck Serono; Pfizer; Sanofi/Aventis
 
Winfried Alsdorf
Honoraria - Astellas Pharma; AstraZeneca; GlaxoSmithKline; Janssen
Consulting or Advisory Role - Janssen
Research Funding - Affimed NV (Inst); BioNTech (Inst)
Travel, Accommodations, Expenses - BioNTech; Immatics; Janssen
 
Dejka Araujo
Research Funding - Adaptimmune (Inst); GlaxoSmithKline (Inst); Immatics (Inst)
 
Antonia Busse
Honoraria - MSD
Consulting or Advisory Role - AstraZeneca; Gilead Sciences; Iovance Biotherapeutics; MSD
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Manik Chatterjee
No Relationships to Disclose
 
Leonel Hernandez-Aya
Consulting or Advisory Role - Bristol-Myers Squibb; Castle Biosciences; Massive Bio; Replimune; Replimune
Speakers' Bureau - Sanofi/Regeneron
Research Funding - Amgen (Inst); Bristol-Myers Squibb (Inst); Corvus Pharmaceuticals (Inst); Foghorn Therapeutics (Inst); immatics (Inst); immatics (Inst); Immunocore (Inst); MedImmune (Inst); Merck (Inst); Merck Serono (Inst); Moderna Therapeutics (Inst); Polynoma (Inst); Regeneron (Inst); Replimune (Inst); Roche/Genentech (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Castle Biosciences; Sanofi/Regeneron
 
Norbert Hilf
Employment - immatics
Stock and Other Ownership Interests - immatics
Research Funding - Bristol-Myers Squibb/Celgene (Inst); Moderna Therapeutics (Inst)
Patents, Royalties, Other Intellectual Property - Inventor in patents of Immatics biotechnologies GmbH.
 
Tobias Holderried
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb/Celgene; GlaxoSmithKline; Jazz Pharmaceuticals; Kite/Gilead; Novartis; Pfizer; Sanofi
Travel, Accommodations, Expenses - Abbvie; BeiGene; immatics; Janssen Oncology; Jazz Pharmaceuticals; Kite/Gilead; Medac; Sanofi
 
Amir Jazaeri
Stock and Other Ownership Interests - Avenge Bio; Greenfire Bio
Honoraria - Premier Research
Consulting or Advisory Role - Gerson Lehrman Group; Guidepoint Global; Iovance Biotherapeutics; Macrogenics; Sentinel Bio; Theolytics
Research Funding - AstraZeneca (Inst); Avenge Bio (Inst); GlaxoSmithKline (Inst); immatics (Inst); Imunon (Inst); Iovance Biotherapeutics (Inst); Lilly (Inst); Lixte Biotechnology (Inst); Macrogenics (Inst); Merck (Inst)
Travel, Accommodations, Expenses - Stryker
 
M. Alper Kursunel
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics
Research Funding - Immatics
Patents, Royalties, Other Intellectual Property - Immatics
Travel, Accommodations, Expenses - Immatics
 
Andrea Mayer-Mokler
Employment - Immatics
Stock and Other Ownership Interests - Immatics
Patents, Royalties, Other Intellectual Property - Immatics
 
Regina Mendrzyk
Employment - immatics
Stock and Other Ownership Interests - immatics
Travel, Accommodations, Expenses - immatics
 
Ali Mohamed
Employment - Immatics
Stock and Other Ownership Interests - Immatics
Research Funding - Immatics
Patents, Royalties, Other Intellectual Property - Immatics
Travel, Accommodations, Expenses - Immatics
 
Sapna Patel
Honoraria - Cedars Sinai; Clinical Care Options; Clinical Education Alliance (Inst); Emory University; OncLive/MJH Life Sciences; Paradigm; University of Michigan; Vindico Medical Education (Inst)
Consulting or Advisory Role - Bristol Myers Squibb; Cardinal Health; Castle Biosciences; IDEAYA Biosciences; immatics; IO Biotech; MSD; Novartis; Obsidian Therapeutics; OncoSec; Pfizer; Replimune; TriSalus Life Sciences
Speakers' Bureau - BMS GmbH & Co. KG; MSD; Novartis
Research Funding - Bristol-Myers Squibb (Inst); Foghorn Therapeutics (Inst); IDEAYA Biosciences (Inst); InxMed (Inst); Lyvgen Biopharma (Inst); Novartis (Inst); Provectus (Inst); Seagen (Inst); Syntrix Biosystems (Inst); TriSalus Life Sciences (Inst)
Travel, Accommodations, Expenses - BMS GmbH & Co. KG; Castle Biosciences; InxMed; Melanoma Research Alliance (MRA); Melanoma Research Foundation; MSD; SITC/ACCC; SWOG; TriSalus Life Sciences
 
Ran Reshef
Consulting or Advisory Role - Allogene Therapeutics; Autolus Therapeutics; Gilead Sciences; Incyte; Orca Bio; Quell Biotherapeutics; Sana Biotechnology; TScan Therapeutics
Research Funding - Abbvie (Inst); Atara Biotherapeutics (Inst); Bristol-Myers Squibb (Inst); Cabaletta Bio (Inst); CareDX (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); immatics (Inst); Incyte (Inst); Janssen (Inst); Precision Biosciences (Inst); Sanofi (Inst); Synthekine (Inst); Takeda (Inst); TCR2 Therapeutics (Inst); TScan Therapeutics (Inst)
Expert Testimony - Bayer
Travel, Accommodations, Expenses - Gilead Sciences; Janssen
 
Apostolia Tsimberidou
Consulting or Advisory Role - Avstera; BioEclipse Therapeutics; BrYet; Macrogenics; Nex-I; Vincerx Pharma
Research Funding - Abbvie (Inst); Agenus (Inst); Anaveon (Inst); BrYet; IMMATICS (Inst); Macrogenics (Inst); Novocure (Inst); OBI Pharma (Inst); Orionis (Inst); Parker Institute for Cancer Immunotherapy (Inst); Tachyon (Inst); Tempus (Inst); Tempus (Inst); Tvardi Therapeutics (Inst); Vividion Therapeutics (Inst)
 
Steffen Walter
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics
Research Funding - Immatics
Patents, Royalties, Other Intellectual Property - Immatics
Travel, Accommodations, Expenses - Immatics
 
Toni Weinschenk
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics
Patents, Royalties, Other Intellectual Property - Immatics
 
Jason Luke
Stock and Other Ownership Interests - Actym Therapeutics; Kanaph Therapeutics; NeoTX; Onc.AI; Pyxis; Tempest Therapeutics
Consulting or Advisory Role - Abbvie; Alphamab; Bayer; Bright Peak Therapeutics; Bristol-Myers Squibb; Hotspot Therapeutics; Incyte; Merck; Novartis; Onc.AI; Pfizer; Regeneron; Tempest Therapeutics; Werewolf Therapeutics; Xilio Therapeutics
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Bristol-Myers Squibb (Inst); Ikena Oncology (Inst); Immatics (Inst); Macrogenics (Inst); Merck (Inst); Moderna Therapeutics (Inst); Numab (Inst); Takeda (Inst); Tizona Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Serial #15/612,657 (Cancer Immunotherapy),; Serial #PCT/US18/36052 (Microbiome Biomarkers for Anti-PD-1/PD-L1 Responsiveness: Diagnostic, Prognostic and Therapeutic Uses Thereof)
Travel, Accommodations, Expenses - Merck
 
Cedrik Britten
Employment - Immatics
Leadership - Immatics
Stock and Other Ownership Interests - Immatics